BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-17
5:42 pm
Purchase
2024-12-1313GPieris Pharmaceuticals, Inc.
PIRS
BIOTECHNOLOGY VALUE FUND L P1,168,117
9.990%
1,168,117increase
(New Position)
Filing